المؤلفون: Dr. PH Andrej Rasch

المصدر: Monitor Versorgungsforschung, Vol 2024, Iss 01, Pp 38-43 (2024)

مصطلحات موضوعية: kinderarzneimittel, pädiatrie, amnog, nutzenbewertung, paediatric use marketing authorisation, klinische studien, Public aspects of medicine, RA1-1270, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.monitor-versorgungsforschung.de/abstract/kinderarzneimittel-und-besonderheiten-von-paediatrischenTest-studien-im-amnog/; https://doaj.org/toc/1866-0533Test; https://doaj.org/toc/2509-8381Test

الوصول الحر: https://doaj.org/article/e9f0fd374f6f4102884899514debf197Test

المؤلفون: Pedrini, Giulia

المصدر: mediAzioni; Vol. 41 (2024); A1-A32 ; mediAzioni; V. 41 (2024); A1-A32 ; 1974-4382

مصطلحات موضوعية: Fachsprache der Medizin, klinische Studien, Terminologie, Fachübersetzung, kontrastive Analyse, LSP of medicine, clinical studies, terminology, specialised translation, contrastive analysis

وصف الملف: application/pdf

العلاقة: https://mediazioni.unibo.it/article/view/16422/17701Test; https://mediazioni.unibo.it/article/view/16422Test

الإتاحة: https://doi.org/10.6092/issn.1974-4382/16422Test
https://mediazioni.unibo.it/article/view/16422Test

المؤلفون: Kessler, L, Niklas, C, Blumenstock, M, Ganzinger, M, Dugas, M

المصدر: 68. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS); 20230917-20230921; Heilbronn; DOCAbstr. 287 /20230915/

مصطلحات موضوعية: klinische Studien, elektronische Behandlungsdaten, KIS-integrierte elektronische Datenerfassung, ddc: 610

العلاقة: Brooke J. SUS: A quick and dirty usability scale. In: Jordan PW, Thomas B, Weerdmeester BA, McClelland IL, editors. Usability Evaluation in Industry. Taylor & Francis; 1996. p. 189-194.; Greulich L, Hegselmann S, Dugas M. An Open-Source, Standard-Compliant, and Mobile Electronic Data Capture System for Medical Research (OpenEDC): Design and Evaluation Study. JMIR Med Inform. 2021;9(11):e29176.; http://dx.doi.org/10.3205/23gmds112Test; http://nbn-resolving.de/urn:nbn:de:0183-23gmds1121Test; http://www.egms.de/en/meetings/gmds2023/23gmds112.shtmlTest

الإتاحة: https://doi.org/10.3205/23gmds112Test
http://nbn-resolving.de/urn:nbn:de:0183-23gmds1121Test
http://www.egms.de/en/meetings/gmds2023/23gmds112.shtmlTest

المؤلفون: Friedrichs, M

المصدر: GMS Medizinische Informatik, Biometrie und Epidemiologie; VOL: 19; DOC02 /20230704/

مصطلحات موضوعية: clinical trials, bioinformatics, metadata, software, klinische Studien, Bioinformatik, Metadaten, ddc: 610

العلاقة: Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. J Natl Cancer Inst. 2016 Feb;108(2). pii: djv324. DOI:10.1093/jnci/djv324; Brown AS, Patel CJ. A standard database for drug repositioning. Sci Data. 2017 Mar;4:170029. DOI:10.1038/sdata.2017.29; Friedrichs M. BioDWH2: an automated graph-based data warehouse and mapping tool. J Integr Bioinform. 2021 Feb;18(2):167-76. DOI:10.1515/jib-2020-0033; Kury F, Butler A, Yuan C, Fu LH, Sun Y, Liu H, Sim I, Carini S, Weng C. Chia, a large annotated corpus of clinical trial eligibility criteria. Sci Data. 2020 Aug;7(1):281. DOI:10.1038/s41597-020-00620-0; Murali V, Muralidhar YP, Königs C, Nair M, Madhu S, Nedungadi P, Srinivasa G, Athri P. Predicting clinical trial outcomes using drug bioactivities through graph database integration and machine learning. Chem Biol Drug Des. 2022 Aug;100(2):169-84. DOI:10.1111/cbdd.14092; Pantziarka P, Vandeborne L, Bouche G. A Database of Drug Repurposing Clinical Trials in Oncology. Front Pharmacol. 2021;12:790952. DOI:10.3389/fphar.2021.790952; Williams RJ, Tse T, DiPiazza K, Zarin DA. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination. PLoS One. 2015;10(5):e0127242. DOI:10.1371/journal.pone.0127242; http://dx.doi.org/10.3205/mibe000241Test; http://nbn-resolving.de/urn:nbn:de:0183-mibe0002417Test; http://www.egms.de/en/journals/mibe/2023-19/mibe000241.shtmlTest

الإتاحة: https://doi.org/10.3205/mibe000241Test
https://doi.org/10.1093/jnci/djv324Test
https://doi.org/10.1038/sdata.2017.29Test
https://doi.org/10.1515/jib-2020-0033Test
https://doi.org/10.1038/s41597-020-00620-0Test
https://doi.org/10.1111/cbdd.14092Test
https://doi.org/10.3389/fphar.2021.790952Test
https://doi.org/10.1371/journal.pone.0127242Test
http://nbn-resolving.de/urn:nbn:de:0183-mibe0002417Test
http://www.egms.de/en/journals/mibe/2023-19/mibe000241.shtmlTest

المؤلفون: Kuklik, Nils, Hüsing, Anika, Stang, Andreas, Brinkmann, Marcus, Eschenfelder, Christoph C., Weimar, Christian, Diener, Hans-Christoph

مصطلحات موضوعية: ScholarlyArticle, ddc:610, Medizinische Fakultät » Universitätsklinikum Essen » Institut für Medizinische Informatik, Biometrie und Epidemiologie, Medizinische Fakultät » Universitätsklinikum Essen » Zentrum für klinische Studien Essen (ZKSE), intracranial hemorrhage -- anticoagulation -- dabigatran -- idarucizumab -- vitamin-K-antagonists

العلاقة: https://doi.org/10.3389/fneur.2023.1212495Test; https://nbn-resolving.org/urn:nbn:de:hbz:465-20230913-151718-3Test; https://duepublico2.uni-due.de/receive/duepublico_mods_00078880Test; https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00078589/fneur-14-1212495.pdfTest

الإتاحة: https://doi.org/10.3389/fneur.2023.1212495Test
https://nbn-resolving.org/urn:nbn:de:hbz:465-20230913-151718-3Test
https://duepublico2.uni-due.de/receive/duepublico_mods_00078880Test
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00078589/fneur-14-1212495.pdfTest

المؤلفون: Dr. PH Dipl.-Stat. Carsten Schwenke

المصدر: Monitor Versorgungsforschung, Vol 2021, Iss 03, Pp 30-33 (2021)

مصطلحات موضوعية: nutzenbewertung, gemeinsamer bundesausschuss, arzneimittel, zulassung, datenschnitte, ereigniszeitanalyse, zusatznutzen, klinische studien, Public aspects of medicine, RA1-1270, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.monitor-versorgungsforschung.de/Abstracts/Kurzfassungen-2021/mvf-03-21/MVF0321_Kommentar_Schwenke_Datenschnitteew-StandardTest; https://doaj.org/toc/1866-0533Test; https://doaj.org/toc/2509-8381Test

الوصول الحر: https://doaj.org/article/b3d67c63be884508851ce4cb9e93ef6cTest

المؤلفون: Peter Stegmaier

المصدر: Monitor Versorgungsforschung, Vol 2022, Iss 05, Pp 30-31 (2022)

مصطلحات موضوعية: klinische studien, technologien, medidata, methoden, innovationen, Public aspects of medicine, RA1-1270, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.monitor-versorgungsforschung.de/Abstracts/Kurzfassungen_2022/MVF-0522/MVF0522_European-Industry-Research-ReportTest; https://doaj.org/toc/1866-0533Test; https://doaj.org/toc/2509-8381Test

الوصول الحر: https://doaj.org/article/e29fc6c6e016412eafa22d6b999a969bTest

المؤلفون: Özal, D, Arndt, A, Thomé, M

المصدر: GMS Hygiene and Infection Control; VOL: 17; DOC01 /20220117/

مصطلحات موضوعية: antibiotics, antimicrobial resistance, bacteriophages, endolysins, infections, wounds, clinical trials, systematic review, Antibiotika, Antibiotikaresistenz, Bakteriophagen, Bakteriophagen-Therapie, Endolysine, Infektionen, Wunden, klinische Studien, systematisches Review, ddc: 610

العلاقة: Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage. 2011 Mar;1(2):66-85. DOI:10.4161/bact.1.2.15845; Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 2005 Nov-Dec;36(6):697-705. DOI:10.1016/j.arcmed.2005.06.009; Briers Y, Walmagh M, Grymonprez B, Biebl M, Pirnay JP, Defraine V, Michiels J, Cenens W, Aertsen A, Miller S, Lavigne R. Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014 Jul;58(7):3774-84. DOI:10.1128/AAC.02668-14; Brunel AS, Benoit G. Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics? Swiss Med Weekly. 2017;147:15.; Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL;the Burden of AMR Collaborative Group . Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet. 2019 Jan;19(1):56-66. DOI:10.1016/S1473-3099(18)30605-4; Chanishvili N. A literature review of the practical application of bacteriophage research. Nova Science Publishers Inc (2012); 2012.; Chen Y, Batra H, Dong J, Chen C, Rao VB, Tao P. Genetic Engineering of Bacteriophages Against Infectious Diseases. Front Microbiol. 2019;10:954. DOI:10.3389/fmicb.2019.00954; Cieplak T, Soffer N, Sulakvelidze A, Nielsen DS. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Gut Microbes. 2018;9(5):391-9. DOI:10.1080/19490976.2018.1447291; ContraFect, editor. Exebacase: A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects. Aviaible from: https://www.contrafect.com/pipeline/exebacaseTest; Critical Appraisal Skills Programme. CASP Checklist: 12 questions to help you make sense of a Cohort Study. Available from: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Cohort-Study-Checklist_2018.pdfTest; Critical Appraisal Skills Programme. CASP Checklist: 11 questionsto help you make sense of a Randomised Controlled Trial. Available from: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Randomised-Controlled-Trial-Checklist-2018.pdfTest; Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33. DOI:10.1128/MMBR.00016-10; Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, Hatfull GF, Spencer H. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019 05;25(5):730-3. DOI:10.1038/s41591-019-0437-z; Duckworth DH. "Who discovered bacteriophage?". Bact Revievs. 1976 Dec;40(4):793-802.; Duckworth DH, Gulig PA. Bacteriophages: potential treatment for bacterial infections. BioDrugs. 2002;16(1):57-62. DOI:10.2165/00063030-200216010-00006; de Wit J, Totté JEE, van Mierlo MMF, van Veldhuizen J, van Doorn MBA, Schuren FHJ, Willemsen SP, Pardo LM, Pasmans SGMA. Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: A randomized controlled trial. J Allergy Clin Immunol. 2019 Sep;144(3):860-3. DOI:10.1016/j.jaci.2019.05.020; Engler AC, Wiradharma N, Ong ZY, Coady DJ, Hedrick JL, Yang YY. Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections. Nano Today. 2012;7(3):201-22.; Fischetti VA. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol. 2008 Oct;11(5):393-400. DOI:10.1016/j.mib.2008.09.012; Fish R, Kutter E, Bryan D, Wheat G, Kuhl S. Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage - A Case Report. Antibiotics (Basel). 2018 Oct;7(4):. DOI:10.3390/antibiotics7040087; Fish R, Kutter E, Wheat G, Blasdel B, Kutateladze M, Kuhl S. Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. J Wound Care. 2016;25(Sup7):S27-S33.; Friedberg EC. DNA damage and repair. Nature. 2003 Jan;421(6921):436-40. DOI:10.1038/nature01408; Gerstmans H, Criel B, Briers Y. Synthetic biology of modular endolysins. Biotechnol Adv. 2018 May-Jun;36(3):624-40. DOI:10.1016/j.biotechadv.2017.12.009; Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance. Trends Microbiol. 2019 Apr;27(4):323-38. DOI:10.1016/j.tim.2018.12.010; Ghosh C, Haldar J. Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides. ChemMedChem. 2015 Oct;10(10):1606-24. DOI:10.1002/cmdc.201500299; Guo M, Feng C, Ren J, Zhuang X, Zhang Y, Zhu Y, Dong K, He P, Guo X, Qin J. A Novel Antimicrobial Endolysin, LysPA26, against. Front Microbiol. 2017;8:293. DOI:10.3389/fmicb.2017.00293; Gupta P, Singh HS, Shukla VK, Nath G, Bhartiya SK. Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study. Int J Low Extrem Wounds. 2019 Jun;18(2):171-5. DOI:10.1177/1534734619835115; Hancock REW, Lehrer R. Cationic peptides: a new source of antibiotics. Trend Biotech. 1998;16(2):82-8.; Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2019 Jan;19(1):35-45. DOI:10.1016/S1473-3099(18)30482-1; Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, Soete O, François PM, Teodorescu S, Verween G, Verbeken G, De Vos D, Pirnay JP. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit Care. 2017 Jun;21(1):129. DOI:10.1186/s13054-017-1709-y; Johnson CT, Sok MCP, Martin KE, Kalelkar PP, Caplin JD, Botchwey EA, García AJ. Lysostaphin and BMP-2 co-delivery reduces infection and regenerates critical-sized segmental bone defects. Sci Adv. 2019 05;5(5):eaaw1228. DOI:10.1126/sciadv.aaw1228; Jun SY, Jang IJ, Yoon S, Jang K, Yu KS, Cho JY, Seong MW, Jung GM, Yoon SJ, Kang SH. Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers. Antimicrob Agents Chemother. 2017 Jun;61(6):. DOI:10.1128/AAC.02629-16; Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):300-5. DOI:10.4103/joacp.JOACP_349_15; Medolysin Wundspray: Prospektive multizentrische einarmige Kohortenstudie zur Beurteilung der Leistungsfähigkeit und Sicherheit eines Wundsprays bei der Behandlung chronischer Wunden. Projektnummer 2018-18. In: Klinikum Nürnberg, editor. Studienregister. Available from: https://clinicalsite.org/~klinikum-nuernberg/de/cat/2113/trial/424Test; Konai MM, Bhattacharjee B, Ghosh S, Haldar J. Recent Progress in Polymer Research to Tackle Infections and Antimicrobial Resistance. Biomacromolecules. 2018 Jun;19(6):1888-917. DOI:10.1021/acs.biomac.8b00458; Leitner L, Sybesma W, Chanishvili N, Goderdzishvili M, Chkhotua A, Ujmajuridze A, Schneider MP, Sartori A, Mehnert U, Bachmann LM, Kessler TM. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial. BMC Urol. 2017 Sep;17(1):90. DOI:10.1186/s12894-017-0283-6; Ludwig T. Was lange währt, wird endlich. zugelassen? LaborJournal. 2019 Nov;11:16-9.; Lusiak-Szelachowska M, Zaczek M, Weber-Dabrowska B, Miedzybrodzki R, Klak M, Fortuna W, Letkiewicz S, Rogóz P, Szufnarowski K, Jonczyk-Matysiak E, Owczarek B, Górski A. Phage neutralization by sera of patients receiving phage therapy. Viral Immunol. 2014 Aug;27(6):295-304. DOI:10.1089/vim.2013.0128; Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci. 2017 Nov;249:100-33. DOI:10.1016/j.cis.2017.05.014; Marinelli LJ, Hatfull GF, Piuri M. Recombineering: A powerful tool for modification of bacteriophage genomes. Bacteriophage. 2012 Jan;2(1):5-14. DOI:10.4161/bact.18778; Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Górski A. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. 2009 Dec;9(4):303-12. DOI:10.1007/s10238-009-0044-2; Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. Available from https://synthesismanual.jbi.globalTest; Morozova VV, Vlassov VV, Tikunova NV. Applications of Bacteriophages in the Treatment of Localized Infections in Humans. Front Microbiol. 2018;9:1696. DOI:10.3389/fmicb.2018.01696; Nilsson AC, Janson H, Wold H, Fugelli A, Andersson K, Håkangård C, Olsson P, Olsen WM. LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus. Antimicrob Agents Chemother. 2015 Jan;59(1):145-51. DOI:10.1128/AAC.03513-14; Park S, Jun SY, Kim CH, Jung GM, Son JS, Jeong ST, Yoon SJ, Lee SY, Kang SH. Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis. Sci Rep. 2018 01;8(1):18. DOI:10.1038/s41598-017-18535-z; Patel DR, Bhartiya SK, Kumar R, Shukla VK, Nath G. Use of Customized Bacteriophages in the Treatment of Chronic Nonhealing Wounds: A Prospective Study. Int J Low Extrem Wounds. 2021 Mar;20(1):37-46. DOI:10.1177/1534734619881076; Pires DP, Cleto S, Sillankorva S, Azeredo J, Lu TK. Genetically Engineered Phages: a Review of Advances over the Last Decade. Microbiol Mol Biol Rev. 2016 Sep;80(3):523-43. DOI:10.1128/MMBR.00069-15; Rahim K, Saleha S, Zhu X, Huo L, Basit A, Franco OL. Bacterial Contribution in Chronicity of Wounds. Microb Ecol. 2017 Apr;73(3):710-21. DOI:10.1007/s00248-016-0867-9; Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009 Jun;18(6):237-8, 240-3. DOI:10.12968/jowc.2009.18.6.42801; Roach DR, Donovan DM. Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage. 2015 Jul-Sep;5(3):e1062590. DOI:10.1080/21597081.2015.1062590; Rodríguez-Rubio L, Martínez B, Donovan DM, Rodríguez A, García P. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol. 2013 Nov;39(4):427-34. DOI:10.3109/1040841X.2012.723675; Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M, Huq S, Qadri F, Talukdar K, Kassam M, Delley M, Loiseau C, Deng Y, El Aidy S, Berger B, Brüssow H. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine. 2016 Feb;4:124-37. DOI:10.1016/j.ebiom.2015.12.023; Schmelcher M, Loessner MJ. Bacteriophage endolysins: applications for food safety. Curr Opin Biotechnol. 2016 Feb;37:76-87. DOI:10.1016/j.copbio.2015.10.005; Schmelcher M, Shen Y, Nelson DC, Eugster MR, Eichenseher F, Hanke DC, Loessner MJ, Dong S, Pritchard DG, Lee JC, Becker SC, Foster-Frey J, Donovan DM. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother. 2015 May;70(5):1453-65. DOI:10.1093/jac/dku552; Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00954-17. DOI:10.1128/AAC.00954-17; Science Gateway, editor. Protocols - Cell Biology Protocols - MOI, pfu, and TCID50. Available from: https://www.sciencegateway.org/protocols/cellbio/cell/moipfu.htmTest; Scorciapino MA, Rinaldi AC. Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics. Front Immunol. 2012;3:171. DOI:10.3389/fimmu.2012.00171; Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001 Mar;45(3):649-59. DOI:10.1128/AAC.45.3.649-659.2001; Teyssieres E, Corre JP, Antunes S, Rougeot C, Dugave C, Jouvion G, Claudon P, Mikaty G, Douat C, Goossend PL Guichard G. Proteolytically Stable Foldamer Mimics of Host-Defense Peptides with Protective Activities in a Murine Model of Bacterial Infection. J Med Chem. 2016 Aug;59(18):8221-32. DOI:10.1021/acs.jmedchem.6b00144; Totté J, de Wit J, Pardo L, Schuren F, van Doorn M, Pasmans S. Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial). Trials. 2017 08;18(1):404. DOI:10.1186/s13063-017-2118-x; Totté JEE, van Doorn MB, Pasmans SGMA. Successful Treatment of Chronic Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases. Case Rep Dermatol. 2017 May-Aug;9(2):19-25. DOI:10.1159/000473872; Weber-Dabrowska B, Mulczyk M, Górski A. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proc. 2003 Jun;35(4):1385-6. DOI:10.1016/s0041-1345(03)00525-6; Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2014 Jan;5(1):226-35. DOI:10.4161/viru.25991; World Health Organization. Antibiotic resistance. 2020 Jul. Avaible from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistanceTest; Wright A, Hawkins CH, Anggård EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol. 2009 Aug;34(4):349-57. DOI:10.1111/j.1749-4486.2009.01973.x; Wu M, Hu K, Xie Y, Liu Y, Mu D, Guo H, Zhang Z, Zhang Y, Chang D, Shi Y. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against. Front Microbiol. 2018;9:3302. DOI:10.3389/fmicb.2018.03302; Yang H, Yu J, Wei H. Engineered bacteriophage lysins as novel anti-infectives. Front Microbiol. 2014 Oct 16;5:542. DOI:10.3389/fmicb.2014.00542; Yang H, Linden SB, Wang J, Yu J, Nelson DC, Wei H. A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method. Sci Rep. 2015 Nov;5:17257. DOI:10.1038/srep17257; Zharkova MS, Orlov DS, Golubeva OY, Chakchir OB, Eliseev IE, Grinchuk TM, Shamova OV. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic? Resistance Front Cell Infect Microbiol. 2019;9:128. DOI:10.3389/fcimb.2019.00128; http://dx.doi.org/10.3205/dgkh000404Test; http://nbn-resolving.de/urn:nbn:de:0183-dgkh0004046Test; http://www.egms.de/en/journals/dgkh/2022-17/dgkh000404.shtmlTest

الإتاحة: https://doi.org/10.3205/dgkh000404Test
https://doi.org/10.4161/bact.1.2.15845Test
https://doi.org/10.1128/AAC.02668-14Test
https://doi.org/10.1016/S1473-3099Test(18)30605-4
https://doi.org/10.3389/fmicb.2019.00954Test
https://doi.org/10.1080/19490976.2018.1447291Test
https://doi.org/10.1128/MMBR.00016-10Test
https://doi.org/10.1038/s41591-019-0437-zTest
https://doi.org/10.2165/00063030-200216010-00006Test
https://doi.org/10.1016/j.jaci.2019.05.020Test

المؤلفون: Striebich, S, Oganowski, T, Ocker, R, Ayerle, GM

المصدر: 5th International Conference of the German Association of Midwifery Science (DGHWi); 20200213-20200214; Bochum; DOC20dghwiW05 /20200211/

مصطلحات موضوعية: midwifery education, professional competency, clinical trial, Qualifizierung von Hebammen, klinische Kompetenzentwicklung, klinische Studien, ddc: 610

العلاقة: Ziel-Mentoring Akademie, Pfungstadt. [Zugriff Sep 2019]. Verfügbar unter: http://www.zm-akademie.deTest; Ayerle GM, Schäfers R, Mattern E, Striebich S,Haastert B,Vomhof M,Icks A, Ronniger Y, Seliger G. Effects of the birthing room environment on vaginal births and client-centred outcomes for women at term planning a vaginal birth: BE-UP, a multicentre randomised controlled trial. Trials. 2018; 19(1): 641. DOI:10.1186/s13063-018-2979-7; http://dx.doi.org/10.3205/20dghwi16Test; http://nbn-resolving.de/urn:nbn:de:0183-20dghwi168Test; http://www.egms.de/en/meetings/dghwi2020/20dghwi16.shtmlTest

الإتاحة: https://doi.org/10.3205/20dghwi16Test
https://doi.org/10.1186/s13063-018-2979-7Test
http://nbn-resolving.de/urn:nbn:de:0183-20dghwi168Test
http://www.egms.de/en/meetings/dghwi2020/20dghwi16.shtmlTest

المؤلفون: Schmidt, Carsten Oliver, Fluck, Juliane, Golebiewski, Martin, Grabenhenrich, Linus, Hahn, Horst, Kirsten, Toralf, Klammt, Sebastian, Löbe, Matthias, Sax, Ulrich, Thun, Sylvia, Pigeot, Iris, The NFDI4Health Task Force Covid-19

المصدر: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 64(9):1084-1092

مصطلحات موضوعية: Epidemiology, COVID-19, Public health, COVID-19 study portal, Clinical trials, Klinische Studien, Epidemiologie, COVID-19-Studienportal, FAIR principles, FAIR-Prinzipien

العلاقة: https://repository.publisso.de/resource/frl:6429845Test; https://doi.org/10.1007/s00103-021-03386-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298983Test/

الإتاحة: https://doi.org/10.1007/s00103-021-03386-xTest
https://repository.publisso.de/resource/frl:6429845Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298983Test/